Delivery Order SPE2DB25D7056-SPE2DB25FTLUZ

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,620.00 Firm Fixed Price Delivery Order contract is for the supply of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of July 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
The U.S. government, through the Defense Logistics Agency (DLA), awarded a $12,407.04 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. The IDC serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560630637 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $1,508.28 and a period of performance through April 19, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $2,627.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,468.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.97 delivery order is for the supply of 4559421846 - Telmisartan 40 mg Tablets, a cardiovascular medication. The award is not designated under any set-aside program, indicating open competition. It is a firm fixed-price contract with a completion date of December 20, 2022. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,490.05 Firm Fixed Price Delivery Order covers the supply of Telmisartan-HCTZ 40-12.5 mg tablets to support federal healthcare programs. The award is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,315.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566915791 - TELMISARTAN 40 MG TABLET 30S, with an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with an ID of SPE2DB20D1109 and SPE2DB25FN41R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,780.28 for the delivery of 4566962954 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. This award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Telmisartan 40 mg tablets. The award, valued at $1,293.60, is a Firm Fixed Price delivery order contract that will run through February 4, 2025. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTLUZ
    Delivery Order

This federal contract award, valued at $1,040, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support federal healthcare programs.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:32 AM